Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Shift work disrupts the body's natural clock, leading to health problems.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

More research is needed to understand how testosterone is maintained in adult males.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Women with AGA have higher lipid levels, increasing heart disease risk.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Endocrine therapies for cancer significantly increase the risk of hair loss.